000 01344 a2200373 4500
005 20250513061206.0
264 0 _c19930518
008 199305s 0 0 eng d
022 _a0022-3565
040 _aNLM
_beng
_cNLM
100 1 _aBurns, L A
245 0 0 _aGallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cApr 1993
300 _a178-86 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aArsenic
_xtoxicity
650 0 4 _aArsenicals
650 0 4 _aB-Lymphocytes
_xcytology
650 0 4 _aCell Adhesion Molecules
_xmetabolism
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aFemale
650 0 4 _aGallium
_xtoxicity
650 0 4 _aIntercellular Adhesion Molecule-1
650 0 4 _aLymphocyte Function-Associated Antigen-1
_xmetabolism
650 0 4 _aMice
650 0 4 _aMitogens
_xpharmacology
650 0 4 _aReceptors, Interleukin-2
_xbiosynthesis
650 0 4 _aSpleen
_xcytology
650 0 4 _aT-Lymphocytes
_xcytology
700 1 _aMunson, A E
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 265
_gno. 1
_gp. 178-86
999 _c8096565
_d8096565